Skip to main content

Advertisement

Log in

Gender Differences in Hypertension: Myths and Reality

  • Hypertension and the Heart (PW de Leeuw and AH Gradman, Section Editors)
  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

Life expectancy is longer in women compared to men, and cardiovascular events occur at a lower rate and at a later age in females than males. The impact of gender on the prevalence, the presentation, and the long-term outcome of cardiovascular disease has long been a topic of active research. Gender differences have been found in several studies but opposite findings also exist. The impact of gender in hypertension and antihypertensive therapy remains poorly clarified. The prevalence, awareness, treatment, and control rates of hypertension exhibit some differences between the two sexes, which are age-dependent. The female advantage in the cardiovascular risk of hypertensive patients might be attenuated by comorbidities and target organ damage. Another aspect of major clinical importance is whether gender differences exist on the effects of antihypertensive agents in blood pressure reduction and cardiovascular morbidity and mortality. The aim of this review is to critically evaluate recent data regarding gender differences in hypertension and incorporate new data into the body of existing knowledge.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Kannel WB, Schwartz MJ, McNamara PM. Blood pressure and risk of cardiovascular disease: the Framingham Heart Study. Chest. 1969;56:43–51.

    Article  CAS  Google Scholar 

  2. Reeves MJ, Bushnell CD, Howard G, et al. Sex differences in stroke: epidemiology, clinical presentation, medical care and outcomes. Lancet Neurol. 2008;7:915–26.

    Article  PubMed  Google Scholar 

  3. Wong C, Froelicher E, Bacchetti P, et al. In a managed care setting, are there sex differences in the use of coronary angiography after acute myocardial infarction? Am Heart J. 1998;135:435–42.

    Article  PubMed  CAS  Google Scholar 

  4. Melloni C, Berger JS, Wang TY, et al. Representation of women in randomized clinical trials of cardiovascular disease prevention. Circulation. 2010;3:135–42.

    PubMed  Google Scholar 

  5. •• Go A, Mozaffarian D, Roger V, et al. Heart disease and stroke statistics – 2013 update: a report from the American Heart Association. Circulation. 2013;127:e77–86. A very significant annual report showing higher awareness, treatment, and control rates among women compared to men. Control rates were consistently higher in men for decades and this trend was reversed for the first time.

    Article  Google Scholar 

  6. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008. JAMA. 2010;303:2043–50.

    Article  PubMed  CAS  Google Scholar 

  7. Fletcher RD, Amdur RL, Kolodner R, et al. Blood pressure control among US veterans: a large multiyear analysis of blood pressure data from the Veterans Administration health data repository. Circulation. 2012;125:2462–8.

    Article  PubMed  Google Scholar 

  8. McDonald M, Hertz RP, Unger AN, Lustik MB. Prevalence, awareness, and management of hypertension, dyslipidemia, and diabetes among United States adults aged 65 and older. J Gerontol A Biol Sci Med Sci. 2009;64:256–63.

    Article  PubMed  Google Scholar 

  9. Daugherty SL, Masoudi FA, Ellis JL, et al. Age-dependent gender differences in hypertension management. J Hypertens. 2011;29:1005–11.

    Article  PubMed  CAS  Google Scholar 

  10. Robitaille C, Dai S, Waters C, et al. Diagnosed hypertension in Canada: incidence, prevalence and associated mortality. CMAJ. 2012;184:E49–56.

    Article  PubMed  Google Scholar 

  11. Prince M, Ebrahim S, Acosta D, et al. Hypertension prevalence, awareness, treatment and control among older people in Latin America, India and China: a 10/66 cross-sectional population-based survey. J Hypertens. 2011;30:177–87.

    Article  Google Scholar 

  12. Gee M, Bienek A, McAlister F, et al. Factors associated with lack of awareness and uncontrolled high blood pressure among Canadian adults with hypertension. Can J Cardiol. 2012;28:375–82.

    Article  PubMed  Google Scholar 

  13. Orshal JM, Khalil RA. Gender, sex hormones, and vascular tone. Am J Physiol Regul Integr Comp Physiol. 2004;286:R233–49.

    Article  PubMed  CAS  Google Scholar 

  14. • Wang L, Szklo M, Folsom A, et al. Endogenous sex hormones, blood pressure change, and risk of hypertension in post-menopausal women: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis. 2012;224:228–34. An important study that uncovers the role of sex hormones in blood pressure elevation in post-menopausal women.

    Article  PubMed  CAS  Google Scholar 

  15. Casiglia E, Tikhonoff V, Caffi S, et al. Menopause does not affect blood pressure and risk profile, and menopausal women do not become similar to men. J Hypertens. 2008;26:1983–92.

    Article  PubMed  CAS  Google Scholar 

  16. Carter J, Fu Q, Minson C, Joyner M. Ovarian cycle and sympathoexcitation in premenopausal women. Hypertension. 2013;61:395–9.

    Article  PubMed  CAS  Google Scholar 

  17. Tsuda K. Roles of sex steroid hormones and nitric oxide in the regulation of sympathetic nerve activity in women. Hypertension. 2013;61:e36.

    Article  PubMed  CAS  Google Scholar 

  18. Hart E, Charkoudian N, Wallin B, et al. Sex and ageing differences in resting arterial pressure regulation: the role of b-adrenergic receptors. J Physiol (London). 2011;589:5285–97.

    Article  CAS  Google Scholar 

  19. Doumas M, Faselis C, Papademetriou V. Renal sympathetic denervation in hypertension. Curr Opin Nephrol Hypertens. 2011;20:647–53.

    Article  PubMed  Google Scholar 

  20. •• Schlaich M, Straznicky N, Grima M, et al. Renal denervation: a potential new treatment modality for polycystic ovary syndrome? J Hypertens. 2011;29:991–6. A very significant proof-of-concept study which highlighted the role of sympathetic nervous system in the pathogenesis of polycystic ovary syndrome. Renal sympathetic denervation not only reduced blood pressure but also improved the severity of the disease itself.

    Article  PubMed  CAS  Google Scholar 

  21. Rands V, Dale M, Kobori H, Prieto M. Sexual dimorphism in urinary angiotensinogen excretion during chronic angiotensin II-salt hypertension. Gend Med. 2012;9:207–18.

    Article  PubMed  Google Scholar 

  22. Perchere-Bertschi A, Burnier M. Female sex hormones, salt, and blood pressure regulation. Am J Hypertens. 2004;17:994–1001.

    Article  Google Scholar 

  23. Forman J, Stampfer M, Curhan G. Diet and lifestyle risk factors associated with incident hypertension in women. JAMA. 2009;302:401–11.

    Article  PubMed  CAS  Google Scholar 

  24. Kittikulsuth W, Sullivan J, Pollock D. ET-1 actions in the kidney: evidence for sex differences. Br J Pharmacol. 2013;168:318–26.

    Article  PubMed  CAS  Google Scholar 

  25. Kittikulsuth W, Pollock J, Pollock D. Sex differences in renal medullary endothelin receptor function in angiotensin II hypertensive rats. Hypertension. 2011;58:212–8.

    Article  PubMed  CAS  Google Scholar 

  26. Cheng S, Xanthakis V, Sullivan L, Vasan R. Blood pressure tracking over the adult life course. Hypertension. 2012;60:1393–9.

    Article  PubMed  CAS  Google Scholar 

  27. Sangiorgi G, Roversi S, Biondi-Zoccai G, et al. Sex-related differences in carotid plaque features and inflammation. J Vasc Surg. 2013;57:338–44.

    Article  PubMed  Google Scholar 

  28. Ota H, Reeves M, Zhu D, et al. Sex differences in patients with asymptomatic carotid atherosclerotic plaque. In vivo 3.0-T magnetic resonance study. Stroke. 2010;41:1630–5.

    Article  PubMed  Google Scholar 

  29. Den Harrog A, Algra A, Moll F, de Borst G. Mechanisms of gender-related outcome differences after carotid endarterectomy. J Vasc Surg. 2010;52:1062–71.

    Article  Google Scholar 

  30. Ong K, Tso A, Lam K, Cheung B. Gender difference in blood pressure control and cardiovascular risk factors in Americans with diagnosed hypertension. Hypertension. 2008;51:1142–8.

    Article  PubMed  CAS  Google Scholar 

  31. Go A, Mozaffarian D, Roger V, et al. Heart disease and stroke statistics – 2013 update: a report from the American Heart Association. Circulation. 2013;127:e59–67.

    Article  Google Scholar 

  32. Yanes L, Reckelhoff J. Postmenopausal hypertension. Am J Hypertens. 2011;24:740–9.

    Article  PubMed  Google Scholar 

  33. Wakabayashi I. Stronger associations of obesity with prehypertension and hypertension in young women than in young men. J Hypertens. 2012;30:1423–9.

    Article  PubMed  CAS  Google Scholar 

  34. Deng WW, Wang J, Liu MM, et al. Body mass index compared with abdominal obesity indicators in relation to prehypertension and hypertension in adults: the CHPSNE study. Am J Hypertens. 2013;26:58–67.

    Article  PubMed  Google Scholar 

  35. Go A, Mozaffarian D, Roger V, et al. Heart disease and stroke statistics – 2013 update: a report from the American Heart Association. Circulation. 2013;127:e72–6.

    Article  Google Scholar 

  36. • Wei G, Coady S, Goff D, et al. Blood pressure and the risk of developing diabetes in African American and Whites. Diabetes Care. 2011;34:873–9. An important analysis of data from three large studies (ARIC, CARDIA, Framingham) revealing that the development of diabetes depends on baseline blood pressure and incident diabetes among hypertensive patients is more frequent in female African-Americans and male Caucasians.

    Article  PubMed  Google Scholar 

  37. • Stocks T, van Hemelrijck M, Manjer J, et al. Blood pressure and risk of cancer incidence and mortality in the metabolic syndrome and cancer project. Hypertension. 2012;59:802–10. A significant study suggesting that hypertension might be associated with cancer in women but not in men. However, further research is needed in this field before jumping to definite conclusions.

    Article  PubMed  CAS  Google Scholar 

  38. • Cuspidi C, Rescaldani M, Sala C, et al. Prevalence of electrocardiographic left ventricular hypertrophy in human hypertension: an updated review. J Hypertens. 2012;30:2066–73. A valuable meta-analysis showing that left ventricular hypertrophy, as assessed by electrocardiography, is more prevalent in men than in women with hypertension.

    Article  PubMed  CAS  Google Scholar 

  39. Okin P, Gerdts E, Kjeldsen S, et al. Gender difference in regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy. Hypertension. 2008;52:100–6.

    Article  PubMed  CAS  Google Scholar 

  40. Piro M, Della Bona R, Abbate A, et al. Sex-related differences in myocardial remodeling. J Am Coll Cardiol. 2010;55:1057–65.

    Article  PubMed  CAS  Google Scholar 

  41. Koster NK, Reddy YM, Schima SM, Almeida NJ. Gender-specific echocardiographic findings in nonagenarians with cardiovascular disease. Am J Cardiol. 2010;105:273–6.

    Article  PubMed  Google Scholar 

  42. Foll D, Jung B, Schilli E, et al. Magnetic resonance tissue phase mapping of myocardial motion: new insight in age and gender. Circ Cardiovasc Imaging. 2010;3:54–64.

    Article  PubMed  Google Scholar 

  43. Borlaug BA, Redfield MM. Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum. Circulation. 2011;123:2006–14.

    Article  PubMed  Google Scholar 

  44. Borlaug BA, Olson TP, Lam CS, et al. Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. J Am Coll Cardiol. 2010;56:845–54.

    Article  PubMed  Google Scholar 

  45. Hamburg NM, Palmisano J, Larson MG, et al. Relation of brachial and digital measures of vascular function in the community: the Framingham heart study. Hypertension. 2011;57:390–6.

    Article  PubMed  CAS  Google Scholar 

  46. Chantler PD, Melenovsky V, Schulman SP, et al. The sex-specific impact of systolic hypertension and systolic blood pressure on arterial-ventricular coupling at rest and during exercise. Am J Physiol. 2008;295:H145–53.

    CAS  Google Scholar 

  47. Rossi P, Frances Y, Kingwell BA, Ahimastos AA. Gender differences in artery wall biomechanical properties throughout life. J Hypertens. 2011;29:1023–33.

    Article  PubMed  CAS  Google Scholar 

  48. Shim CY, Park S, Choi D, et al. Sex differences in central hemodynamics and their relationship to left ventricular diastolic function. J Am Coll Cardiol. 2011;57:1226–33.

    Article  PubMed  Google Scholar 

  49. Sinning C, Wild P, Echevarria F, et al. Sex differences in early carotid atherosclerosis (from the community-based Gutenberg-Heart study). Am J Cardiol. 2011;107:1841–7.

    Article  PubMed  Google Scholar 

  50. Neugarten J, Acharaya A, Silbiger S. Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol. 2000;11:319–29.

    PubMed  CAS  Google Scholar 

  51. Ix J, Chonchol M, Laughlin G, Shlipak M, Whooley M. Relation of sex and estrogen therapy to serum fibroblast growth factor 23, serum phosphorus, and urine phosphorus: the Heart and Soul study. Am J Kidney Dis. 2011;58:737–45.

    Article  PubMed  CAS  Google Scholar 

  52. Doublier S, Lupia E, Catanuto P, Elliot S. Estrogens and progression of diabetic kidney damage. Curr Diabetes Rev. 2011;7:28–34.

    Article  PubMed  CAS  Google Scholar 

  53. Mueisan M, Ambrosioni E, Costa F, et al. Sex differences in hypertension-related renal and cardiovascular diseases in Italy: the I-DEMAND study. J Hypertens. 2012;30:2378–86.

    Article  Google Scholar 

  54. Schiller J, Lucas J, Peregoy J. Summary health statistics for US adults: National Health Interview Survey 2010. Vital Health Stat. 2012;252:1–207.

    Google Scholar 

  55. AIHW. Women and heart disease: cardiovascular profile of women in Australia. Report. Cardiovascular disease series no 33. Cat no CVD 49. 2010.

  56. Prince S, Adamo K, Hamel M, et al. A comparison of direct versus self-reported measures for assessing physical activity in adults: a systematic review. Int J Behav Nutr Phys Act. 2008;5:56–67.

    Article  PubMed  Google Scholar 

  57. Bursztyn M, Ben-Dov I. Sex differences in salt-sensitivity risk approximated from ambulatory blood pressure monitoring and mortality. J Hypertens. 2013;31:900–5.

    Article  PubMed  CAS  Google Scholar 

  58. Benetos A, Thomas A, Joly L, et al. Pulse pressure amplification, a mechanical biomarker of cardiovascular risk. J Am Coll Cardiol. 2010;55:1032–7.

    Article  PubMed  Google Scholar 

  59. • Regnault V, Thomas F, Safar M, et al. Sex difference in cardiovascular risk: role of pulse pressure amplification. J Am Coll Cardiol. 2012;59:1771–7. An important study proposing pulse pressure amplification as a novel potential predictor of cardiovascular risk.

    Article  PubMed  Google Scholar 

  60. Rothwell P, Howard S, Dolan E, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010;375:895–905.

    Article  PubMed  Google Scholar 

  61. Rothwell P, Howard S, Dolan E, et al. Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol. 2010;9:469–80.

    Article  PubMed  CAS  Google Scholar 

  62. Schutte R, Thijs L, Liu YP, et al. Within-subject blood pressure level – not variability – predicts fatal and nonfatal outcomes in a general population. Hypertension. 2012;60:1138–47.

    Article  PubMed  CAS  Google Scholar 

  63. Peters R, Wells F, Bulpitt C, Beckett N. Impact of transiently elevated diastolic pressure on cause of death: 29-year follow-up from the General Practice Hypertension Study Group. J Hypertens. 2013;31:71–6.

    Article  PubMed  CAS  Google Scholar 

  64. Pencina M, D’Agostino R, Larson M, Massaro J, Vasan R. Predicting the 30-year risk of cardiovascular disease: the Framingham Heart Study. Circulation. 2009;119:3078–84.

    Article  PubMed  Google Scholar 

  65. Mounier-Vehier C, Simon T, Guedj-Meynier D, et al. Gender-related differences in the management of hypertension by cardiologists: the PARITE study. Arch Cardiovasc Dis. 2012;105:271–80.

    Article  PubMed  Google Scholar 

  66. Ciambrone G, Kaski J. The importance of gender differences in the diagnosis and management of cardiovascular disease. Curr Pharm Des. 2011;17:1079–81.

    Article  PubMed  CAS  Google Scholar 

  67. • Boggia J, Thijs L, Hansen T, et al. Ambulatory blood pressure monitoring in 9357 subjects from 11 populations highlights missed opportunities for cardiovascular prevention in women. Hypertension. 2011;57:397–405. This significant clinical study in a large number of patients showed that the preventable cardiovascular risk is significantly higher in women than in men.

    Article  PubMed  CAS  Google Scholar 

  68. Lykke J, Langhoff-Roos J, Sibai B, et al. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension. 2009;53:944–51.

    Article  PubMed  CAS  Google Scholar 

  69. McDonald S, Malinowski A, Zhou Q, Yusuf S, Devereaux P. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J. 2008;156:918–30.

    Article  PubMed  Google Scholar 

  70. Bellamy L, Casas J, Hingorani A, Williams D. Preeclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335:974–86.

    Article  PubMed  Google Scholar 

  71. Mongraw-Chaffin M, Cirillo P, Cohn B. Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort. Hypertension. 2010;56:166–71.

    Article  PubMed  CAS  Google Scholar 

  72. Mosca L, Benjamin E, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women – 2011 update: a guideline from the American Heart Association. Circulation. 2011;123:1243–62.

    Article  PubMed  Google Scholar 

  73. • Schmittdiel J, Selby J, Swain B, et al. Missed opportunities in cardiovascular disease prevention? Low rates of hypertension recognition for women at medicine and obstetrics-gynecology clinics. Hypertension. 2011;57:717–22. This significant report highlights missed opportunities in everyday clinical practice for female cardiovascular risk prevention due to physicians’ lack of familiarity with the future cardiovascular sequelae of preeclampsia.

    Article  PubMed  CAS  Google Scholar 

  74. Basu R, Krueger P, Lairson D, Franzini L. Lifetime medical expenditures among hypertensive men and women in the United States. Women Health Issues. 2011;21:246–53.

    Article  Google Scholar 

  75. Franco O, Peeters A, Bonneux L, de Laet C. Blood pressure in adulthood and life expectancy with cardiovascular disease in men and women: life course analysis. Hypertension. 2005;46:280–6.

    Article  PubMed  CAS  Google Scholar 

  76. Redon J, Olsen M, Cooper R, et al. Stroke mortality and trends from 1990 to 2006 in 39 countries from Europe and Central Asia: implications for control of high blood pressure. Eur Heart J. 2011;32:1424–31.

    Article  PubMed  Google Scholar 

  77. Martinez-Selles M, Doughty R, Poppe K, et al. Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient meta-analysis. Eur J Heart Fail. 2012;14:473–9.

    Article  PubMed  Google Scholar 

  78. Ford E. Trends in mortality from all causes and cardiovascular disease among hypertensive and nonhypertensive adults in the United States. Circulation. 2011;123:1737–44.

    Article  PubMed  Google Scholar 

  79. Wieberdink R, Ikram M, Hofman A, Koudstaal P, Breteler M. Trends in stroke incidence rates and stroke risk factors in Rotterdam, the Netherlands from 1990 to 2008. Eur J Epidemiol. 2012;27:287–95.

    Article  PubMed  Google Scholar 

  80. Go A, Mozaffarian D, Roger V, et al. Heart disease and stroke statistics – 2013 update: a report from the American Heart Association. Circulation. 2013;127:e109–21.

    Article  Google Scholar 

  81. Daugherty S, Masoudi F, Zeng C, et al. Sex differences in cardiovascular outcomes in patients with incident hypertension. J Hypertens. 2013;31:271–7.

    Article  PubMed  CAS  Google Scholar 

  82. Kloner R, Sowers J, DiBona G, et al. Sex- and age-related antihypertensive effects of amlodipine. The Amlodipine Cardiovascular Community Trial Study Group. Am J Cardiol. 1996;77:713–22.

    Article  PubMed  CAS  Google Scholar 

  83. Saunders E, Cable G, Neutel J. Predictors of blood pressure response to angiotensin receptor blocker/diuretic combination therapy: a secondary analysis of the irbesartan/hydrochlorothiazide blood pressure reductions in diverse patient populations (INCLUSIVE) study. J Clin Hypertens (Greenwich). 2008;10:27–33.

    CAS  Google Scholar 

  84. Everett BM, Glynn RJ, Danielson E, Ridker PM. Combination therapy versus monotherapy as initial treatment for stage 2 hypertension: a prespecified subgroup analysis of a community-based, randomized, open-label trial. Clin Ther. 2008;30:661–72.

    Article  PubMed  CAS  Google Scholar 

  85. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981–97.

    Article  Google Scholar 

  86. Zanchetti A, Julius S, Kjeldsen S, et al. Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: an analysis of findings from the VALUE trial. J Hypertens. 2006;24:2163–8.

    Article  PubMed  CAS  Google Scholar 

  87. b-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA. 1982;247:1707–14.

    Article  Google Scholar 

  88. Fletcher A, Beevers DG, Bulpitt C, et al. Beta adrenoceptor blockade is associated with increased survival in male but not female hypertensive patients: a report from the DHSS Hypertension Care Computing Project (DHCCP). J Hum Hypertens. 1988;2:219–27.

    PubMed  CAS  Google Scholar 

  89. Wing L, Reid C, Ryan P, et al. A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med. 2003;348:583–92.

    Article  PubMed  CAS  Google Scholar 

  90. Turnbull F, Woodward M, Neal B, et al. Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials. Eur Heart J. 2008;29:2669–80.

    Article  PubMed  Google Scholar 

  91. Keyhani S, Scobie JV, Hebert PL, McLaughlin MA. Gender disparities in blood pressure control and cardiovascular care in a national sample of ambulatory care visits. Hypertension. 2008;51:1149–55.

    Article  PubMed  CAS  Google Scholar 

  92. Schoofs MW, van der Klift M, Hofman A, et al. Thiazide diuretics and the risk for hip fracture. Ann Intern Med. 2003;139:476–82.

    Article  PubMed  Google Scholar 

  93. Lewis CE, Grandits A, Flack J, McDonald R, Elmer PJ. Efficacy and tolerance of antihypertensive treatment in men and women with stage 1 diastolic hypertension. Results of the Treatment of Mild Hypertension Study. Arch Intern Med. 1996;156:377–85.

    Article  PubMed  CAS  Google Scholar 

  94. Os I, Franco V, Kjeldsen SE, et al. Effects of losartan in women with hypertension and left ventricular hypertrophy: results from the Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension. 2008;51:1103–8.

    Article  PubMed  CAS  Google Scholar 

  95. Mas S, Gasso P, Alvarez S, et al. Pharmacogenetic predictors of angiotensin-converting enzyme inhibitor-induced cough: the role of ACE, ABO, and BDKRB2 genes. Pharmacogenet Genomics. 2011;21:531–8.

    Article  PubMed  CAS  Google Scholar 

  96. Pemu PI, Ofili E. Hypertension in women—part I. J Clin Hypertens (Greenwich). 2008;10:406–10.

    Article  Google Scholar 

  97. Manolis A, Doumas M. Antihypertensive treatment and sexual dysfunction. Curr Hypertens Rep. 2012;14:285–92.

    Article  PubMed  CAS  Google Scholar 

  98. Viigimaa M, Doumas M, Vlachopoulos C, et al. Hypertension and sexual dysfunction: time to act. J Hypertens. 2011;29:403–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of Interest

Michael Doumas declares that he has no conflict of interest

Vasilios Papademetriou declares that he has no conflict of interest

Charles Faselis declares that he has no conflict of interest

Peter Kokkinos declares that he has no conflict of interest

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael Doumas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Doumas, M., Papademetriou, V., Faselis, C. et al. Gender Differences in Hypertension: Myths and Reality. Curr Hypertens Rep 15, 321–330 (2013). https://doi.org/10.1007/s11906-013-0359-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-013-0359-y

Keywords

Navigation